< Back to search trials

A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789)

  • Clinicaltrials.gov #: NCT03515837
  • Acronym: KEYNOTE 789
  • Tumor Type: Lung
  • Tumor Subtype: Non-Small Cell Lung Cancer
  • Tumor Stage: Metastatic (1st line)
  • Type of Treatment: